Thus, these results imply that S100A14 enhances breast cancer cell and macrophage migration and invasion via CCL2 and CXCL5, and the S100A14-CCL2/CXCL5 axis acts as a driver of breast cancer metastasis. Here, CCL2 is linked to breast carcinoma.